The general goal of this project is to further understand the
regulation and function of the gene products that form the recently
discovered epithelial Na channel. the context in which these studies
are undertaken relates to the pathogenesis of salt-sensitive
hypertension. There are 2 subprojects. The first subproject
capitalizes on new information indicating that primary cultures of
the renal inner medullary collecting duct from salt-sensitive rates
transport substantially more Nathan do these cells cultured from
salt-resistant rats. The hypothesis derived from this data is that an
abnormality in the epithelial Na channel complex, or in associated
regulatory molecules, contributes to the pathogenesis of salt-
sensitive hypertension in humans. the experiments are directed at 3
specific aims. The first aim is to determine the effect of
physiologic maneuvers known to alter the activity of collecting duct
Na transport on the messenger RNA and protein of each of the 3
major subunits. The focus will be on the kidney and uroepithelium,
but responses in lung and colon will be measured in order to
examine tissue heterogeneity. The second aim is to determine the
biophysical properties of the epithelial Na channel as it exists in the
apical membrane of inner medullary collecting duct cells from salt-
sensitive and salt-resistant rats. the third aim is to determine the
effect of overexpressing one or more of the epithelial Nachannel
subunits in the inner medullary collecting duct on Na transport.
Using transgenic mice, the rate-limiting subunit will be selectively
overexpressed and the animals examined for their salt-sensitivity.
These experiments will test the hypothesis that an overactive Na
channel in the inner medullary collecting duct will contribute to
salt-sensitive hypertension.
The second subproject is based on the new observation that the
uroepithelium contains epithelial Nachannel subunits. The
experiments proposed in this portion will test the hypothesis that
these subunits serve a different function that they do in the
collecting duct. Rather than participate in Na reabsorption, the
hypothesis is that they participate in activation of mechanosensitive
nerve fibers. In the renal pelvis, afferent nerve activity is markedly
activated by an increase in renal pelvic pressure. Preliminary data
suggest that the epithelial Nachannel subunits participate in this
activity. the specific aims are to determine the mechanisms by
which ameliorate modulates the activation of afferent renal nerve
activity. to determine the extent to which ameliorate inhibits the
release of putative mediators of mechanoreceptor activation, and to
determine the effect of elimination of one of the subunits in
genetically altered mice on the activation of afferent renal nerve
activity. These experiments will test a novel hypothesis which may
have important implications for an interaction of Na channel
function and the central nervous system.
National Institute of Diabetes and Digestive and Kidney Diseases
CFDA Code
DUNS Number
062761671
UEI
Z1H9VJS8NG16
Project Start Date
17-July-1998
Project End Date
30-June-1999
Budget Start Date
01-October-1997
Budget End Date
30-September-1998
Project Funding Information for 1998
Total Funding
$160,099
Direct Costs
Indirect Costs
Year
Funding IC
FY Total Cost by IC
1998
National Institute of Diabetes and Digestive and Kidney Diseases
$160,099
Year
Funding IC
FY Total Cost by IC
Sub Projects
No Sub Projects information available for 1P50DK052617-02 0001
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 1P50DK052617-02 0001
Patents
No Patents information available for 1P50DK052617-02 0001
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 1P50DK052617-02 0001
Clinical Studies
No Clinical Studies information available for 1P50DK052617-02 0001
News and More
Related News Releases
No news release information available for 1P50DK052617-02 0001
History
No Historical information available for 1P50DK052617-02 0001
Similar Projects
No Similar Projects information available for 1P50DK052617-02 0001